glp-1 adoption Receptor Agonist Market Size & Analysis, 2026-2033 Broader Impact of Adoption of

The STEP 1 trial extension The most cited data comes from the STEP 1 trial extension, published in Diabetes, Obesity and Metabolism

Conclusions The present case study suggests the potential anti-addiction benefit of semaglutide, with the drug being associated with a substantial reduction in AUD-associated cravings and clinically meaningful declines in the patients alcohol consumption

Incidence varies by individual, but electrolyte depletion and rapid metabolic shift are well-established triggers

That quieting of food noise, the relentless inner stream of cravings, urges and preoccupations around eating, sits at the heart of a new study from researchers at the Stanford Center for Digital Health, published in JAMA Network Open

doi: 10.1038/nature11808 84 MontandonS

doi: 10.1016/S0140-6736(18)32261-X 13 GersteinHCColhounHMDagenaisGRDiazRLakshmananMPaisPet al